University of Cincinnati Cancer Center — Cincinnati, Ohio

University of Cincinnati Cancer Center is a clinical research site located in Cincinnati, Ohio, United States 45267.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Cincinnati Cancer Center has participated in 21 clinical trials with 12 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, Endometrial Adenocarcinoma, Non-muscle Invasive Bladder Cancer.

Sponsors: Delta-Fly Pharma, Inc., Acrivon Therapeutics, ImmunityBio, Inc..

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Cincinnati Cancer Center?

University of Cincinnati Cancer Center has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Cincinnati Cancer Center conducted?

University of Cincinnati Cancer Center has 21 clinical trials on record, with 12 currently active. Their work covers Leukemia, Myeloid, Acute, Endometrial Adenocarcinoma, Non-muscle Invasive Bladder Cancer.

Is University of Cincinnati Cancer Center accredited by Crixeo Health?

Yes — University of Cincinnati Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Cincinnati Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.